• Recombinant Mouse IFN-γ in MASH-HCC Assays

  2026-09-22

  Use Recombinant Mouse IFN-γ to test whether impaired antigen presentation in MASH-HCC cells is reversible, pathway-dependent, or intrinsically blocked. This workflow connects controlled cytokine stimulation with MHC-I, NLRC5, macrophage, T-cell, and antiviral bioactivity readouts.

• DFO, Ferroptosis and Translational Precision

  2026-09-21

  DFO is a powerful forensic fluorescence reagent, but its acronym can be confused with deferoxamine in biomedical research. This thought-leadership article connects the mechanistic discipline of latent fingerprint chemistry with findings from silver nanoparticle-induced ferroptosis in zebrafish, while defining the evidence and identity controls required for responsible translational use.

• Meropenem trihydrate in Resistance Metabolomics

  2026-09-21

  Meropenem trihydrate connects phenotypic antibiotic challenge with LC-MS/MS analysis of bacterial resistance. This workflow helps distinguish drug-response effects from carbapenemase-associated metabolic signatures while improving assay design, controls, and troubleshooting.

• MLKL Polymerization Drives Lysosomal Permeabilization

  2026-09-20

  The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a key execution step in necroptosis. By combining live-cell imaging with cathepsin B perturbation and MLKL-domain experiments, it links lysosomal rupture to the release of cytotoxic proteases and shows that cathepsin B is an important driver of downstream cell death.

• Tetracycline for Mechanistic Assay Design

  2026-09-19

  Tetracycline is more than a routine antibiotic selection reagent: it can help structure reproducible microbiological and engineered-cell workflows when its ribosomal activity, solvent behavior, and assay boundaries are understood. This article connects tetracycline workflow design with the QRICH1–HMGB1 findings reported in HBV-associated hepatic fibrosis research.

• 3D Proteomics and Carboplatin Response in HGSOC

  2026-09-19

  The 2025 Journal of Proteome Research study quantitatively compared whole-cell proteomes from four high-grade serous ovarian carcinoma models grown in 2D monolayers and 3D spheroids. Its findings show that culture dimensionality reshapes energy metabolism, membrane-associated proteins, and carboplatin response, providing a stronger rationale for integrating 3D models into proteomics-guided preclinical oncology research.

• Honokiol in CD8+ T Cell Metabolism

  2026-09-18

  Use Honokiol to connect NF-κB, oxidative-stress, viability, and immunometabolic readouts in activated CD8+ T-cell assays. This workflow translates the CD28-ARS2-PKM findings into a hypothesis-testing platform while clearly separating established evidence from exploratory compound use.

• Safe DNA Gel Stain for RNAi Gel Workflows

  2026-09-17

  Safe DNA Gel Stain supports blue-light visualization of DNA and RNA during RNAi validation, cloning, and routine gel-based analysis. Its flexible in-gel or post-electrophoresis formats can help protect excised DNA from UV-associated damage while preserving practical workflow control.

• Carboplatin Workflows for Resistance Research

  2026-09-17

  Carboplatin supports reproducible DNA-damage, cytotoxicity, and resistance studies across ovarian, lung, and triple-negative breast cancer models. This workflow connects dose-response design with cancer stem-cell assays, formulation controls, and combination testing to distinguish true resistance from experimental variability.

• METTL14–SMN Control of m6A Homeostasis

  2026-09-16

  The reference study identifies an arginine methylation-dependent interaction between METTL14 and the SMN protein, connecting post-translational regulation of the m6A writer complex with spinal muscular atrophy-associated defects. Its cellular, patient-derived, and mouse-model experiments further link impaired m6A deposition to DNA repair gene expression, genotoxic sensitivity, embryonic development, and hematopoiesis.

• Reparixin: CXCR1/2 Inhibitor Workflow for IL-8 Studies

  2026-09-16

  Reparixin enables receptor-level testing of CXCL8-driven neutrophil migration, inflammatory injury, and tumor-associated signaling. This workflow connects an MRSA extracellular-vesicle discovery to practical chemotaxis, OSCC, acute lung injury research, and ischemia-reperfusion injury model designs while separating established evidence from experimental extensions.

• Selective Spectrophotometric Analysis of β-Lactams

  2026-09-15

  The reference study developed two direct, selective spectrophotometric procedures for four phenolic β-lactam antibiotics by converting them with cerium(IV) or iron(III) into an intensely yellow product. Its practical contribution was a relatively simple alternative to chromatographic testing for pharmaceutical formulations, including amoxicillin combinations containing structurally related penicillins.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-09-15

  The 2022 Cancers study identified increased sensitivity of ATRX-deficient high-grade glioma cells to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its most clinically relevant implication is that ATRX status may help interpret RTK inhibitor responses and guide combinations with temozolomide, although validation beyond cell models remains necessary.

• Arsenic, ROS, NF-κB, and HK2 in the Warburg Effect

  2026-09-14

  The reference study identifies a mechanistic ROS/NF-κB/HK2 axis linking low-dose arsenic exposure with a glycolytic, proliferation-supporting phenotype in human L-02 hepatocytes. Its integrated use of metabolic, oxidative-stress, signaling, and proliferation readouts provides a useful framework for studying toxicant-associated glucose reprogramming.

• Biotin-tyramide for Spatial Signal Amplification

  2026-09-14

  Biotin-tyramide converts localized horseradish peroxidase activity into a flexible biotin deposition signal for sensitive IHC and ISH. This workflow guide connects practical TSA optimization with the spatial-biology logic of proximity labeling while clearly separating fixed-sample detection from live-cell APEX methods.

8642 records 4/577 page Previous Next 12345 下5页 Last page